The conversation around addiction has evolved dramatically over recent decades, with medical and scientific communities now firmly classifying it as a chronic brain disorder rather
When the results of the first-ever platform trial for amyotrophic lateral sclerosis (ALS) were published this February, the headlines might have seemed disappointing: four experimental